Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,823,816
  • Shares Outstanding, K 110,886
  • Annual Sales, $ 298,850 K
  • Annual Income, $ -542,730 K
  • 60-Month Beta 1.41
  • Price/Sales 57.17
  • Price/Cash Flow N/A
  • Price/Book 21.56
Trade TXG with:

Options Overview Details

View History
  • Implied Volatility 50.51%
  • Historical Volatility 36.11%
  • IV Percentile 32%
  • IV Rank 26.40%
  • IV High 71.70% on 03/04/21
  • IV Low 42.92% on 09/10/21
  • Put/Call Vol Ratio 4.05
  • Today's Volume 96
  • Volume Avg (30-Day) 510
  • Put/Call OI Ratio 3.06
  • Today's Open Interest 280
  • Open Int (30-Day) 180

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.18
  • Number of Estimates 5
  • High Estimate -0.09
  • Low Estimate -0.25
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
137.37 +17.65%
on 10/04/21
165.91 -2.59%
on 09/21/21
-0.19 (-0.12%)
since 09/20/21
3-Month
137.37 +17.65%
on 10/04/21
191.15 -15.45%
on 09/07/21
-20.37 (-11.19%)
since 07/20/21
52-Week
125.84 +28.42%
on 11/10/20
208.99 -22.67%
on 06/29/21
+8.65 (+5.66%)
since 10/20/20

Most Recent Stories

More News
Wall Street Analysts See a 27% Upside in 10x Genomics (TXG): Can the Stock Really Move This High?

The mean of analysts' price targets for 10x Genomics (TXG) points to a 26.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

TXG : 161.61 (+0.54%)
Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

CERN : 72.06 (+0.91%)
OMCL : 165.01 (+1.17%)
INSP : 251.54 (+0.41%)
TXG : 161.61 (+0.54%)
10x Genomics to Report Third Quarter Financial Results on November 3, 2021

/PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2021 after market close on Wednesday,...

TXG : 161.61 (+0.54%)
Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges

Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.

TXG : 161.61 (+0.54%)
CERN : 72.06 (+0.91%)
OMCL : 165.01 (+1.17%)
INSP : 251.54 (+0.41%)
Here's Why 10x Genomics (TXG) is Poised for a Turnaround After Losing 22.3% in 4 Weeks

10x Genomics (TXG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising...

TXG : 161.61 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 167.24
2nd Resistance Point 164.92
1st Resistance Point 163.26
Last Price 161.61
1st Support Level 159.28
2nd Support Level 156.96
3rd Support Level 155.30

See More

52-Week High 208.99
Fibonacci 61.8% 177.23
Fibonacci 50% 167.42
Last Price 161.61
Fibonacci 38.2% 157.60
52-Week Low 125.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar